Guangdong Zhongsheng Pharmaceutical Co., Ltd. Stock

Equities

002317

CNE100000HW4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
15.17 CNY -0.46% Intraday chart for Guangdong Zhongsheng Pharmaceutical Co., Ltd. +7.44% -5.48%

Financials

Sales 2024 * 3.12B 431M 593M Sales 2025 * 3.43B 474M 653M Capitalization 12.86B 1.78B 2.45B
Net income 2024 * 401M 55.39M 76.26M Net income 2025 * 443M 61.19M 84.25M EV / Sales 2024 * 4.12 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.75 x
P/E ratio 2024 *
32.3 x
P/E ratio 2025 *
29.2 x
Employees 1,732
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71.02%
More Fundamentals * Assessed data
Dynamic Chart
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhongsheng Pharma's Chairman to Raise Stake in Company MT
Zhongsheng Pharma's Unit Gets Nod to Market Mirabegron MT
Zhongsheng Pharma Chairman Plans Boosting Stake MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhongsheng Pharmaceutical Gets Drug Registration Certificate for Carbocysteine Oral Solution MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhongsheng Pharmaceutical Gets Nod to Register Moxifloxacin Hydrochloride Eye Drops MT
Zhongsheng Pharma Registers Mucolytic in China MT
Zhongsheng Pharmaceutical Unit Completes Phase III Clinical Trial of Flu Drug MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd.(SZSE:002317) added to Shenzhen Stock Exchange Component Index CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd.(SZSE:002317) added to Shenzhen Stock Exchange Component A Share Index CI
Zhongsheng Pharma Enrols Subjects in Phase IIb Clinical Trial of NASH Drug MT
Zhongsheng Pharm Unit Enrolls First Subject for RAY1225 Injection Trial MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 May 2023 CI
More news
1 day-0.46%
1 week+7.44%
Current month-5.01%
1 month-5.01%
3 months+13.46%
6 months-14.20%
Current year-5.48%
More quotes
1 week
13.65
Extreme 13.65
15.32
1 month
13.48
Extreme 13.48
16.34
Current year
10.22
Extreme 10.22
18.42
1 year
10.22
Extreme 10.22
22.18
3 years
8.08
Extreme 8.08
41.30
5 years
7.88
Extreme 7.88
41.30
10 years
7.54
Extreme 7.54
41.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 11-01-04
Director of Finance/CFO 52 10-02-07
Director/Board Member 35 18-12-05
Members of the board TitleAgeSince
Chief Executive Officer 54 11-01-04
Director/Board Member 56 10-02-07
Director/Board Member 42 16-12-28
More insiders
Date Price Change Volume
24-04-30 15.17 -0.46% 17,306,400
24-04-29 15.24 +2.28% 16,526,660
24-04-26 14.9 +2.19% 23,180,140
24-04-25 14.58 +2.24% 31,470,530
24-04-24 14.26 +2.08% 13,620,400

End-of-day quote Shenzhen S.E., April 29, 2024

More quotes
Guangdong Zhongsheng Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of medicines. The Company’s medicine products are categorized into Chinese patent medicines, chemical drugs, chemical bulk drugs and herbal decoction pieces, which include capsules for thrombus, pellets for upper respiratory tract diseases, granular for sunstroke, compound dexamethasone acetate creams and azelastine hydrochloride eye drops, among others. The Company distributes its products in domestic market.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
15.17
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. 002317 Stock